FDA Shifts Aim At Loperamide Packaging In War Against Opioid Abuse

As part of its efforts to alleviate the opioid epidemic, the FDA imposed new regulations on loperamide packaging. New blister packs should be smaller, with enough dosage only for short-term treatment.